Home Antheia

Antheia

In operation
Series C
Small Molecule Drug Developer

Basic Information

Antheia is a synthetic biology company that provides next-generation plant-based small molecule drugs, focusing on multiple categories of plant-based drugs that cannot be produced at scale through synthetic chemical processes. Through pioneering whole-cell bioengineering technology, Antheia effectively produces these highly complex drugs by reconstructing unprecedentedly intricate multi-step biosynthetic pathways within yeast cells. With Antheia's technology, we can express dozens of enzymes and transport proteins in cells, transforming them into micro-factories to efficiently construct some of the most complex molecules known to humanity.
Antheia, Inc.
California,United States of America
15~50 people
January 01, 2015
info@antheia.bio